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1. Introduction 
Pulmonary infarction is localized destruction (necrosis) of lung tissue by blocking 
(obstruction of) the arterial blood supply. It  follows an embolic event in ~10% of cases. 
Blockage of pulmonary artery by a clot or air bubble or other particle (called pulmonary 
embolism) leads to localized damage of lung tissue which results in pulmonary infarction (1, 
2). The reasons for this low incidence of pulmonary infarct are the dual blood supply 
systems, as well as oxygenation of the lung tissues via ventilation (3).    
The predisposing factors for pulmonary infarct include congestive heart failure, pleural 
effusion, pulmonary infection, atelectasis, hypotension, positive-pressure ventilation, 
chronic lung disease, central venous catheterization and an immunocompromised state. It is 
more common in people with chronic heart and lung diseases. Infarction condition may be 
mild and can be rapidly fatal (4). 
Common symptoms include chest pain which may be because of difficulty in breathing, 
high pulse rate, mild fever, developing of fluid in the lungs, a productive cough (sputum 
may be blood-tinged). Blockage may also result into circulatory breakdown, like low blood 
pressure, presence of very little oxygen in the blood. Also, swelling of neck vein and leg, 
weakness, restlessness, and fainting. In the case of infection as developing complication, 
there is worsening of the clinical status, persistent  fever, malaise, sweating, increasing pulse 
rate and leukocytosis (usually more than 20 x 109/l) (5).  
Diseases that should be listed in the differential diagnosis include bacterial pneumonia, 
aspergillosis, tuberculosis, norcardia, actinomycosis, and granulomatous vasculitis. Other 
unusual etiologies that should be listed in the differential diagnosis include primary or 
metastatic angiosarcoma or leomyosarcoma and lung cancer invading the main pulmonary 
arteries (6,7).  
2. Clinical presentation  
Bacterial pneumonia and pulmonary infarction frequently mimic each other clinically, 
indicates that most methods for distinguishing between these illnesses are unsatisfactory. Both 
diseases may give rise to dyspnea, pleuritic pain, tachypnoea, fever, cyanosis, hypotension, 
cough, hemopthysis, jaundice, leukocytosis and similar radiographic abnormalities (8).  
Shaking chills point strongly to bacterial pneumonia. Additional hints are a preceding upper 
respiratory tract infection followed by gradually increasing malaise and then cough, usually 
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productive of purulent sputum. Patients with pulmonary infarction more often become ill 
with dramatic suddenness, seldom have a cough and experience shaking chills only if the 
emboli are septic or the infarct become infected (8).  
Physical signs are not specific for either diseases. Although high fever is more typical of 
bacterial pneumonia, it is occurs with sufficient frequency in pulmonary infarction to be 
unreliable as differential diagnostic sign. Patients with pulmonary infarction, as compared 
to those with bacterial pneumonia, generally are more dyspnoic and tachypnoic in relation 
to the extent of their physical and radiographic abnormalities and rarely exhibit classic signs 
of consolidation. They more often manifest hypotension, either transient or recurrent, and 
more commonly show signs suggesting pulmonary hypertension and right-sided congestive 
heart failure, e.g. a loud pulmonis component of the second heart sound and elevation of the 
jugular venous pressure (8).  
A pleural friction rub helps in differentiation only when chest radiography shows no 
parenchymal disease. Then, infarction is more often do not cause radiographic changes early 
in the course of the illness (8). 
3. Laboratory and other diagnostic tests  
Sputum examination is one of the best ways of differentiating bacterial pneumonia from 
pulmonary infarction. In bacterial pneumonia the sputum classically is purulent, 
occasionally foul smelling and may contain bright red fleck of blood. Gram’s stain typically 
shows many bacteria and polymorphonuclear leukocytes. In pulmonary infarction, sputum, 
when present, usually is frankly blood with few bacteria or inflammatory cells. If the infarct 
becomes infected the sputum may be indistinguishable from that in bacterial pneumonia. 
Blood cultures often reveal the causative microorganism in the patients with bacterial 
pneumonia but show no growth in cases of bland pulmonary infarction (8).  
Cavitation after bland pulmonary infarcts may result from either aseptic necrosis of the 
infracted lung or from secondary bacterial infection with subsequent abscess formation. It is 
infective almost as often as it is aseptic (9).  
Two types of infected pulmonary infarct have been proposed based on the mode by which 
infection sets in (10). One is called “primary” because the infection is from a septic embolus. 
The other is called “secondary” because the infection is bronchigenic origin. Some authors 
suggest that the development of fever and/or purulent sputum following a pulmonary 
infarct is highly suspicious for secondary infection. The spectrum of causative agents for 
infected pulmonary infarct is similar to that of nosocomial pneumonia (3).  
Total leukocyte count has limited discriminatory value. It usually is normal or slightly 
elevated in pulmonary infarction, but there is reports of leukocytes count higher than 40 000 
per mm3 in patients with  massive, bland necrosis of pulmonary tissue. Elevated serum 
lactic dehydrogenase (LDH) activity, normal aspartate aminotranspherase activity (AST) 
and increased serum bilirubin concentration forms a triad once considered a sensitive 
indicators of pulmonary embolism and infarction. However, subsequent studies have 
shown that these tests fail to differentiate pulmonary infarction from pneumonia and host of 
other disorders (8). 
Electrocardiographic abnormalities that may appear are right ventricular conduction 
disturbances; right axis deviation; inverted T-waves with S-T segment deviation in the right 
precordial leads; peaked T-waves in leads II, III and AVF; various types of supraventricular 
and raraly ventricular arrhythmias and S1, Q3 or S1,S2, S3 patterns. Heart ultrasound may 
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reveals right ventricular dilatation, septal deviation of left ventricle, tricuspidal 
regurgitation or right ventricle hypokinesis with wall thinning (8, 11).  
Pulmonary function test and arterial blood gas studies provide data that are too variable 
and nonspecific to differentiate bacterial pneumonia from pulmonary infarction (8).  
4. Imaging studies  
Radiographic similarities of bacterial pneumonia and pulmonary infarction are the chief 
source of diagnostic confusion between the two entities. Each is responsible for 
parenchymal infiltrates of varied size and shape, with or without pleural effusion, 
atelectasis or cavitation. In contrast to bacterial pneumonia, pulmonary infarcts always abut 
a pleural surface and predominate in lower lobes, especially the right. They also may appear 
in concert with dilatation of one or both main pulmonary arteries, decreased peripheral 
vascular markins in the affected portion of lung (oligemia) or engorged vassels in the non 
affected areas (pleonemia). Further radiographic clues to pulmonary infarction are infiltrates 
appearing first in one lung and then the other or “pneumonia” unresponsive to 
chemotherapy (8).  
Spiral computed tomography and magnetic resonance angiography are helpful in 
establishing the difference between pneumonia and pulmonary infarct. Also, this imaging 
techniques could help tracking the resolution of the thrombo emboli, but they are expensive 
and unavailable in many hospitals (6,7).  
Pulmonary arteriography is the most specific means of differentiating  bacterial pneumonia 
from pulmonary infarction. In bacterial pneumonia the pulmonary arteries proximal to the 
subsegmental level show neither filling defect nor obstructive lesions, where in pulmonary 
infarction they contain filling defect, appear obstructed, or both (8).  
The grater the size of infarct, more likely its centre will be hypoxic and nectrotic. Pulmonary 
infarct larger than 4 x 4 cm in size have a great tendency for cavitation (12).  
The median time from the first detection of consolidation to cavity formation is 14 days (12).  
Doppler sonography is a noninvasive and convenient tool for diagnosing pulmonary 
embolism and follow-up reperfusion of the lung. Dynamic changes in blood flow in 
consolidated areas provides information about the status of reperfusion (6).  
Despite use of the aforementioned techniques, the question of infected versus infracted lung 
sometimes will persist. To minimize error, the physicians should think of both diseases 
when he considers either, particularly if the process involves the lower lobes, especially the 
right. Dangers of delaying treatment for pulmonary infarction rival the hazards of 
withholding specific chemotherapy in bacterial pneumonia. Thus, as long as the diagnosis 
remains in doubt, treatment for both disorders seems well advised (8). 
Multiple complications have been associated with pulmonary infarct, including pneumonia, 
empyema, pneumothorax, lung abscess, bronchopleural fistulae and lethal haemorrhage. 
Large series of autopsies reveald cavitation in 4-5% of all pulmonary infarcts (5).  
The mortality rate is as high as 41% and 73% for nonifected and infected cavitary pulmonary 
infarcts, respectively. Anticoagulants and antibiotics are the mainstay of therapy. Massive 
haemopthysis may persist even after discontinuation of anticoagulants. Possible explanation 
for this phenomenon are an overdose of anticoagulants and reperfusion of necrotic lung 
tissue. Anticoagulants use in cavitary pulmonary infarction, therefore, must be very 
carefully monitored and causation should be exercised in monitoring clinical conditions and 
the status of coagulation (10).  
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5. Case presentation 
Patient was admitted to our clinic with a three week history of dyspnea, tachycardia, cough, 
expectoration of yellow colored sputum, fever, exhaustion and lower legs edema. Few days 
before admission to clinic he presented altered level of consciousness (mental confusion), 
caused by alcohol withdrawal. The patient suffered from congestive heart failure and 
chronic obstructive pulmonary disease for several years. There was no past medical history 
of predisposition factors for embolism or episodes of venous thrombo-embolism. 
On examination he presented normal mental status, body temperature was within normal 
range, blood pressure 130/80 mmHg, pulse rate 90 beats/min; respiratory rate 26 
breath/min; with signs of peripheral cyanosis. The chest expanded symmetrically and 
breathing sounds were clear. There were heart rhythm disorder (absolute arrhythmia) but 
no heart murmurs were detected. The liver and spleen were not palpable. Lower leg edema 
was noticed. 
The initial laboratory blood test revealed elevated inflammatory parameters: white blood 
cells:15.7 x 109/L; with 87.6% neutrophils; 3.4% monocytes and 9.0% lymphocytes; C-
reactive protein: 73 mg/L; D-dimer: 759 ηg/ml. The prothrombin time, activated partial 
thromboplastin time (PTT) and platelets  were within normal range. There were elevated 
activity of aspartate aminotranspherase (160.6 U/L); alanin aminotransferase (128.0 U/L); 
lactic dehydrogenase (745 U/L); serum bilirubin concentration (45 μmol/L);blood urea 
nitrogen (16.3 mmol/L) and creatinine (120.4 μmol/L). But, all this test has limited 
discriminatory value. 
The arterial gas blood analysis showed the following: pH 7,5; carbon dioxide tension in 
arterial blood (PCO2) 31 mmHg; oxygen tension in arterial blood (PO2) 71 mmHg; HCO3 24 
mmol/L; BE 1 mmol/L and oxygen saturation (SaO2) 95%. 
Lung functional test shown severe restrictive ventilation disorder (FEV1: 8%; FVC: 44% - 
1.67 L; FEV1/FVC: 72%) which is nonspecific to differentiate bacterial pneumonia from 
pulmonary infarction as well as the arterial gas blood analysis too.  
The electrocardiography (ECG) revealed atrial fibrillation only. The initial chest radiograph 
was showed enlarged cardiac shadow without pulmonary opacities (Figure 1) because  
infarction is more often do not cause radiographic changes early in the course of the illness. 
Congestive heart failure was diagnosed and the patient was treated with diuretics and 
inotropes.  
However, a ten days later the intensity of dyspnea, fatique, weakness and exhaustion has 
increased. He was febrile (38.30 C). A contribution to literature data, in our case, clinical 
condition has got worsening suddenly. Chest radiography was significant since it showed 
round pulmonary consolidation with central cavitation on the apical segment of the right 
lower lobe (Figure 2). The patient was placed on antibiotic therapy (intravenous ceftazidine 
and ertapenem) for a presumptive diagnosis of bacterial pneumonia.  
However, one week later, the treatment with antibiotics was not satisfactory and there were 
no clinical recovery. Also, there were no microbiologic confirmation of causative 
microorganism which made definitive diagnosis difficult. The clinical symptoms of 
congestive heart failure was dominant and the patient underwent a cardiac ultrasound 
which revealed tricuspidal regurgitation and elevated right ventricular pressure (systolic 
blood pressure of right ventricule - SPRV: 46 mmHg). The increased intensity of dyspnoea, 
fatique, weakness and exhaustion, despite the treatment with diuretics and inotropes was 
due to unconfirmed hemodynamic disorder.  
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Fig. 1. Initial chest PA (postero-anterior) radiography showing enlarged cardiac shadow 
without pulmonary  opacities 
 
 
Fig. 2. PA (postero-anterior) chest radiography ten days from admission showing round 
pulmonary consolidation with central cavitation on the apical segment of the right lower lobe 
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The most striking and unexpected findings was contrast-enhanced computed tomography 
(CT) scan of blood vessels and identification of filling defect in the main pulmonary arteries 
which presumptive diagnosis of pneumonia excluded. There were pulmonary consolidation 
with central cavitation on the right lower and left upper lobes too. The diameter of  right  
and left  consolidation was 63 x 75 mm and 85 x 70 mm respectively (Figure 3a and 3b). The 
size of pulmonary infarct , in our case, is grater than 40 x 40 mm which explain the 
appearance of cavitation. Also, the velocity of cavity formation presented in our case is 
significantly lower than literature data pointed out. Venous duplex ultrasound of lower 
extremitas was negative for deep-vein thrombosis. Low-molecular heparin were 





Fig. 3a. and 3b. Contrast - enhanced computed tomography scan of blood vessels showing 
filling defect in the main pulmonary arteries with central cavitation on the right  lower and 
left upper lobes too 
www.intechopen.com
 
Cavitary Pulmonary Infarct: The Differential Diagnostic Dilemma – A Case Report 
 
221 
The follow-up chest radiograph (three weeks later) showed regression of mentioned 
pulmonary opacities (Figure 4). Due to anticoagulant therapy was administered 
immediately after the findings of the CT scans were obtained, the patient was clinicaly 
recovered and he was discharged with follow-up recommended. 
 
 
Fig. 4. Follow-up chest radiograph (three weeks later) showing regression of mentioned 
pulmonary opacities. 
6. Conclusion  
Cavitary pulmonary infarct is a rare but frequently misdiagnosed disease entity. 
Differentation between cavitary pulmonary infarct and multiple complications or other 
diseases can be a real challenge because of the similar radiographic abnormalities and 
clinical presentation of all this  conditions. In the cases with clinical suspicion to 
“pneumonia” unresponsive to chemotherapy images studies are of great help. The best 
evidence of infarction is the angiographic demonstration of pulmonary thromboemboli. 
Anticoagulant and antibiotic treatment in the cases of infected cavitary pulmonary infarct 
must be started immediately after the diagnosis is established. 
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